Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

NCT05308732 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Head and Neck Neoplasms
Mucositis Oral
Radiotherapy; Complications

Interventions

DRUG: Copaiba

Sponsor

Instituto Nacional de Cancer, Brazil